$ACOG News

B. Riley Securities Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $21

HC Wainwright & Co. Maintains Buy on Alpha Cognition, Raises Price Target to $20

Alpha Cognition Inc. (ACOG) Q2 2026 Earnings Call Transcript

Alpha Cognition Q2 2026 Earnings Call Transcript

Alpha Cognition Q2 EPS $(0.40) Misses $(0.39) Estimate, Sales $6.092M Beat $4.384M Estimate

Raymond James Initiates Coverage On Alpha Cognition with Outperform Rating, Announces Price Target of $20

Alpha Cognition Appoints Robert Wills As Board Chairman, Succeeding Len Mertz

Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease

Alpha Cognition Enrolls First Patient In RESOLVE, Phase 4 Post-Marketing Clinical Study To Further Evaluate Tolerability Profile, Treatment Experience Associated With ZUNVEYL In Routine Clinical Practice

We Think Alpha Cognition (NASDAQ:ACOG) Needs To Drive Business Growth Carefully

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease

Alpha Cognition Reports Top-Line Results From BEACON Real-World Study Of ZUNVEYL

Maxim Group Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $12

HC Wainwright & Co. Reiterates Buy on Alpha Cognition, Maintains $18 Price Target

Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target

Alpha Cognition Inc. (ACOG) Q1 2026 Earnings Call Transcript

Alpha Cognition Inc. Common Stock Q1 2026 Earnings Call Summary

Alpha Cognition Q1 Earnings Call Highlights

Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimates

Alpha Cognition (NASDAQ:ACOG) Q1 Revenue Meets Estimates as Commercial Momentum Builds